For the Inventor, By the Inventor

Enter assignee name

Buffalo, NY, United States of America

Cleveland Biolabs, Inc.

USPTO Granted Patents = 16

% Expired Patents = 68.8

CIPO Patents = 1

EPO Patents = 5

Forward Citations = 117

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Andrei V Gudkov (14 out of 72 patents)

Anatoli Gleiberman (5 out of 5 patents)

Lyudmila Burdelya (5 out of 6 patents)

4. Alexander Shakhov (4 out of 4 patents)

5. Robert L Fairchild (3 out of 5 patents)

6. Elena Feinstein (3 out of 3 patents)

7. Vadim Krivokrysenko (2 out of 18 patents)

8. Vadim Mett (22 patents)

9. Evguenia Strom (0 patent)

10. Alexander N Shakhov (0 patent)

16 patents: Sort by Forward Citations

1. 11628201 - Use of toll-like receptor agonist for treating cancer (2023-04-18),

2. 10857200 - Methods and compositions for the treatment of radiation-related disorders (2020-12-08),

3. 10780152 - Use of toll-like receptor agonist for treating cancer (2020-09-22),

4. 10265390 - Use of toll-like receptor agonist for treating cancer (2019-04-23),

5. 10183056 - Methods and compositions for the treatment of radiation-related disorders (2019-01-22),

6. 10034926 - Use of toll-like receptor agonist for treating cancer (2018-07-31),

7. 9381225 - Methods of protecting against apoptosis using lipopeptides (2016-07-05),

8. 9376473 - Use of Toll-Like Receptor agonist for treating cancer (2016-06-28),

9. 9006183 - Methods of protecting against apoptosis using lipopeptides (2015-04-14),

10. 9006180 - Methods for treating tourniquet-induced injuries (2015-04-14),

11. 8618059 - Methods for treating reperfusion injuries using flagellin (2013-12-31),

12. 8524668 - Methods of protecting against apoptosis using lipopeptides (2013-09-03),

13. 8324163 - Methods for treating reperfusion injuries using flagellin (2012-12-04),

14. 8242057 - Methods for identifying modulators of apoptosis (2012-08-14),

15. 8008260 - Methods of protecting against apoptosis using lipopeptides (2011-08-30),

Cleveland Biolabs, Inc. is a biotechnology company based in Buffalo, NY, focused on developing innovative therapies for cancer and other serious diseases. The company specializes in leveraging its proprietary technologies to create novel treatments that enhance the body's ability to combat illness and improve patient outcomes. With a commitment to advancing medical science, Cleveland Biolabs engages in extensive research and development to address unmet medical needs through its unique therapeutic approaches.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#21 in Buffalo, NY

#1,158 in New York

#19,907 in US

#37,788 in the World

Buffalo, NY, United States of America

Cleveland Biolabs, Inc.

Forward Citations = 117

7 inventors:

Andrei V Gudkov (14 out of 72 patents)

Anatoli Gleiberman (5 out of 5 patents)

Lyudmila Burdelya (5 out of 6 patents)

4. Alexander Shakhov (4 out of 4 patents)

5. Robert L Fairchild (3 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…